Treatment of Male Pattern Baldness With Botulinum Toxin

This study has been completed.
Sponsor:
Information provided by:
The Crown Institute
ClinicalTrials.gov Identifier:
NCT00965640
First received: August 24, 2009
Last updated: NA
Last verified: August 2009
History: No changes posted
  Purpose

This proof of concept study seeks to demonstrate that Botulinum toxin injections are a safe and effective method for treating this form of hair loss.


Condition Intervention Phase
Male Pattern Baldness
Drug: Botulinum Toxin - A injections
Phase 2

Study Type: Interventional
Study Design: Primary Purpose: Screening
Official Title: A Prospective, Single Center, Open Label, Proof of Principle Study to Assess the Efficacy and Safety of 150 Units of Botulinum Toxin-A Intra-Muscular Injection in the Prevention of Hair Loss in Men With Androgenetic Alopecia

Resource links provided by NLM:


Further study details as provided by The Crown Institute:

Primary Outcome Measures:
  • Hair Growth [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]

Secondary Outcome Measures:
  • Hair Loss [ Time Frame: 1 year ] [ Designated as safety issue: Yes ]

Study Start Date: December 2002
Study Completion Date: June 2004
Primary Completion Date: June 2004 (Final data collection date for primary outcome measure)
  Eligibility

Ages Eligible for Study:   18 Years to 65 Years
Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Criteria

Inclusion Criteria:

  • Male pattern baldness
  • Norwood II-VI

Exclusion Criteria:

  • Treatment with Botulinum toxins or other hair growth interventions with past year
  Contacts and Locations
Please refer to this study by its ClinicalTrials.gov identifier: NCT00965640

Locations
Canada, Ontario
Crown Institute
Pickering, Ontario, Canada, L1V 1B1
Sponsors and Collaborators
The Crown Institute
Investigators
Principal Investigator: Brian Freund, MD Crown Institute
  More Information

No publications provided by The Crown Institute

Additional publications automatically indexed to this study by ClinicalTrials.gov Identifier (NCT Number):
Responsible Party: Dr. B. Freund, Principal Investigator, Crown Institute
ClinicalTrials.gov Identifier: NCT00965640     History of Changes
Other Study ID Numbers: MPB-2002-01, HPB 081023
Study First Received: August 24, 2009
Last Updated: August 24, 2009
Health Authority: Canada: Health Canada

Keywords provided by The Crown Institute:
male pattern baldness
androgenetic alopecia
hair loss

Additional relevant MeSH terms:
Alopecia
Alopecia Areata
Hypotrichosis
Hair Diseases
Skin Diseases
Pathological Conditions, Anatomical
Botulinum Toxins, Type A
Botulinum Toxins
Neuromuscular Agents
Peripheral Nervous System Agents
Physiological Effects of Drugs
Pharmacologic Actions
Anti-Dyskinesia Agents
Central Nervous System Agents
Therapeutic Uses

ClinicalTrials.gov processed this record on April 17, 2014